New innovative campaign weaves science and storytelling to help reframe obesity as a chronic disease INDIANAPOLIS, Nov. 10, 2025 /PRNewswire/ -- For Tan France, clothing has always been about more ...

Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz monotherapy in TOGETHER-PsA study Late-breaking results also ...

Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials Strategic collaboration marks the first time patients ...

The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ...

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance (PASI 100) and ≥10% weight loss In ...

Zepbound (tirzepatide) and Mounjaro (tirzepatide) are prescription drugs used to treat different conditions. Zepbound and Mounjaro are not available as generic drugs. The two drugs have some ...

Zepbound’s starting dose is typically 2.5 milligrams (mg) once per week. Your doctor will gradually increase it, up to a maximum weekly dose of 15 mg. Zepbound’s maintenance dosage ranges from 5 to 15 ...

Zepbound is a prescription subcutaneous injection doctors prescribe for weight loss, weight management and obstructive sleep apnea in adults. Whether you are considering Zepbound or you’ve been using ...

Compared with rival injectables Wegovy and Ozempic (semaglutide), Zepbound leads to greater weight loss. Learn about how it works, pricing, and side effects.

Zepbound (tirzepatide) is a medication that people use for weight loss and obstructive sleep apnea. It can cause various digestive side effects, including diarrhea, which is one of the most common. In ...